Actuate Therapeutics ACTU
NASDAQ ACTU
$0.78 +0.09 (+13.04%)
At close: Sep 30, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Other Non-Current Liabilities (2023 - 2024)

Updated

Actuate Therapeutics' Other Non-Current Liabilities was $1.26 million in Q2 2024.

Analysis

Actuate Therapeutics (ACTU) Other Non-Current Liabilities (2023 - 2024) Analysis & Trends

At the end of FY2023, Other Non-Current Liabilities at Actuate Therapeutics came in at $988,049.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Actuate Therapeutics 18.73 Mn 18.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 1.26 Mn
Dec 31, 2023 988,049.00
API Access

Actuate Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ACTU&period=max&api_key=YOUR_API_KEY